Latest filing published 25 Feb 2014 for NUPATHE INC., €13.7M.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Safeguard Scientifics Inc span 3 companies, the busiest being Clarient, Inc, Nupathe Inc. and Tengion Inc. Over a trading history stretching from 22 September 2006 to 21 February 2014, the count stands at 29 filings.
Both buying and selling appear: 2 purchases worth €3.5M, against 3 sales worth €44.7M. On balance, insiders were net sellers of €41.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 15 share grants.
Most recently, on 25 February 2014, the filings show a transaction worth €13.7M in Nupathe Inc. The clock since the last published purchase (12 April 2010) now reads 6,038 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations